Skip to main content

Table 5 Plasma lipids significantly (p < 0.05) associated with baseline ht-TKV. Effect size represents the magnitude and direction (+/−) of association between a given lipid and ht-TKV, estimated by linear regression, while controlling for the selected HALT covariates, age, sex, genotype, site of sample collection, and BMI

From: Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course

Lipid

Effect Size (SD)

p-value

FDR q-value

Triglyceride(51:3) [M + K]+

0.1626 (0.038)

< 0.0001

0.0031

Triglyceride(53:3) [M + K]+

0.1827 (0.055)

0.0010

0.0492

Sphingomyelin(d43:1) [M + H]+

0.1560 (0.070)

0.0276

0.5728

Triglyceride d5(17:0/17:1/17:0) iSTD [M + Na]+

0.1038 (0.049)

0.0337

0.5728

Triglyceride(54:5) A [M + K]+

0.1350 (0.064)

0.0352

0.5728

Triglyceride(52:3) [M + K]+

0.1719 (0.082)

0.0360

0.5728

  1. bold Q-values indicate signficance, <0.05